In-Q-Tel | GenomeWeb


NEW YORK (GenomeWeb News) – Claremont BioSolutions said today it has entered a strategic partnership with investment firm In-Q-Tel to accelerate commercialization of Claremont's Prep-on-a-Chip sample preparation platform.

This article was originally published May 7.

NEW YORK (GenomeWeb News) – OpGen today announced a collaboration with In-Q-Tel to develop a high-throughput sequence and genome mapping pipeline for microbial genome analysis.

Quanterix said this week that it has received an investment of an undisclosed amount from In-Q-Tel, a non-profit investment firm that delivers technology to the US intelligence community.

The undisclosed investment will support the development of a platform for US intelligence applications that will rely on Biomatrica's technology that enables biological samples to be stored at room temperature.

The investment expands Arxcis' ongoing collaboration with IQT to develop Arcxis' fully automated RNA and DNA sample-preparation device, expected to launch later this year.

MBI plans to use the series B venture funding to develop its Apollo sample prep technologies.

Arcxis received an undisclosed investment from In-Q-Tel, which it will use to accelerate development and commercialization of its nucleic acid sample preparation platform and diagnostic consumable product line.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.